Intervention

GW-1000-02

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5
Recruiting0
Common conditions3
Lead sponsors shown1
Advertisement

Clinical trials

5 shown
A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological OriginNCT01606176 · 2002-03-01
COMPLETED
A Study of the Long-term Safety of Sativex UseNCT01606137 · 2002-02-01
COMPLETED
A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple SclerosisNCT01610687 · 2001-07-01
COMPLETED
An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis PatientsNCT01610700 · 2001-05-01
COMPLETED
An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple SclerosisNCT01610713 · 2001-05-01
COMPLETED

Trial status mix

COMPLETED5

Phase mix

PHASE35

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.